tiprankstipranks
Advertisement
Advertisement

DE:4YB Stock Latest News

Immunovant Earnings Call: Cash Windfall and Key Catalysts
Company AnnouncementsImmunovant Earnings Call: Cash Windfall and Key Catalysts
15d ago
IMVT
Immunovant price target raised to $45 from $43 at BofA
PremiumThe Fly
Immunovant price target raised to $45 from $43 at BofA
23d ago
IMVT
Immunovant Reaffirmed at Buy as IMVT-1402 Trials Advance; $53 Price Target Maintained
PremiumRatings
Immunovant Reaffirmed at Buy as IMVT-1402 Trials Advance; $53 Price Target Maintained
26d ago
IMVT
Immunovant reports Q2 EPS (75c), consensus (61c)
PremiumThe Fly
Immunovant reports Q2 EPS (75c), consensus (61c)
27d ago
IMVT
Immunovant price target raised to $50 from $47 at JPMorgan
PremiumThe Fly
Immunovant price target raised to $50 from $47 at JPMorgan
29d ago
IMVT
Immunovant price target raised to $61 from $57 at Citi
PremiumThe FlyImmunovant price target raised to $61 from $57 at Citi
2M ago
IMVT
Immunovant price target raised to $47 from $35 at JPMorgan
Premium
The Fly
Immunovant price target raised to $47 from $35 at JPMorgan
3M ago
IMVT
Immunovant price target raised to $62 from $44 at Guggenheim
Premium
The Fly
Immunovant price target raised to $62 from $44 at Guggenheim
3M ago
IMVT
Immunovant price target raised to $30 from $23 at Truist
PremiumThe Fly
Immunovant price target raised to $30 from $23 at Truist
3M ago
IMVT
Immunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications
PremiumCompany Announcements
Immunovant’s Talent Crunch: How Human Capital Risks Could Derail IMVT-1402 Development Across Six Indications
3M ago
IMVT
Immunovant price target raised to $43 from $32 at BofA
PremiumThe Fly
Immunovant price target raised to $43 from $32 at BofA
3M ago
IMVT
Immunovant price target raised to $40 from $35 at H.C. Wainwright
PremiumThe Fly
Immunovant price target raised to $40 from $35 at H.C. Wainwright
3M ago
IMVT
Immunovant rises 33.6%
PremiumThe FlyImmunovant rises 33.6%
3M ago
IMVT
Immunovant rises 25.9%
Premium
The Fly
Immunovant rises 25.9%
3M ago
IMVT
Immunovant reports Q4 EPS (73c), consensus (63)
Premium
The Fly
Immunovant reports Q4 EPS (73c), consensus (63)
4M ago
IMVT
Immunovant price target raised to $32 from $29 at Goldman Sachs
PremiumThe Fly
Immunovant price target raised to $32 from $29 at Goldman Sachs
5M ago
IMVT
Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential
PremiumRatings
Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential
5M ago
IMVT
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
PremiumThe Fly
Midday Fly By: Amazon said to eye Globalstar, Tesla deliveries miss consensus
5M ago
F
BP
Buy Rating Maintained on Immunovant as IMVT-1402 Pipeline Overshadows Batoclimab Setback
PremiumRatings
Buy Rating Maintained on Immunovant as IMVT-1402 Pipeline Overshadows Batoclimab Setback
5M ago
IMVT
Immunovant price target lowered to $50 from $52 at Leerink
PremiumThe FlyImmunovant price target lowered to $50 from $52 at Leerink
5M ago
IMVT
Morning Movers: Immunovant sinks after batoclimab trials miss goal
Premium
The Fly
Morning Movers: Immunovant sinks after batoclimab trials miss goal
5M ago
BP
ALK
Video: Globalstar jumps after report of Amazon deal interest
Premium
The Fly
Video: Globalstar jumps after report of Amazon deal interest
5M ago
CVX
DAL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >